Correlation Between Lifecore Biomedical and Rapport Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lifecore Biomedical and Rapport Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lifecore Biomedical and Rapport Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lifecore Biomedical and Rapport Therapeutics, Common, you can compare the effects of market volatilities on Lifecore Biomedical and Rapport Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lifecore Biomedical with a short position of Rapport Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lifecore Biomedical and Rapport Therapeutics,.

Diversification Opportunities for Lifecore Biomedical and Rapport Therapeutics,

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Lifecore and Rapport is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Lifecore Biomedical and Rapport Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rapport Therapeutics, and Lifecore Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lifecore Biomedical are associated (or correlated) with Rapport Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rapport Therapeutics, has no effect on the direction of Lifecore Biomedical i.e., Lifecore Biomedical and Rapport Therapeutics, go up and down completely randomly.

Pair Corralation between Lifecore Biomedical and Rapport Therapeutics,

Given the investment horizon of 90 days Lifecore Biomedical is expected to generate 1.13 times more return on investment than Rapport Therapeutics,. However, Lifecore Biomedical is 1.13 times more volatile than Rapport Therapeutics, Common. It trades about 0.04 of its potential returns per unit of risk. Rapport Therapeutics, Common is currently generating about 0.01 per unit of risk. If you would invest  699.00  in Lifecore Biomedical on October 9, 2024 and sell it today you would lose (12.00) from holding Lifecore Biomedical or give up 1.72% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy29.49%
ValuesDaily Returns

Lifecore Biomedical  vs.  Rapport Therapeutics, Common

 Performance 
       Timeline  
Lifecore Biomedical 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Lifecore Biomedical are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting fundamental indicators, Lifecore Biomedical reported solid returns over the last few months and may actually be approaching a breakup point.
Rapport Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rapport Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Rapport Therapeutics, is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Lifecore Biomedical and Rapport Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lifecore Biomedical and Rapport Therapeutics,

The main advantage of trading using opposite Lifecore Biomedical and Rapport Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lifecore Biomedical position performs unexpectedly, Rapport Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rapport Therapeutics, will offset losses from the drop in Rapport Therapeutics,'s long position.
The idea behind Lifecore Biomedical and Rapport Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges